Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,368 public trials 2,841 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

NCT07437404

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Beijing children's hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Cognitive Remediation Intervention to Prepare for Transition of Care

NCT05336201

Conditions: Adolescent Behavior, Anemia, Anemia, Hemolytic, +18 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Recruiting

A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma

NCT06235229

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Research Site Beijing, China

Research Site Beijing, China

Research Site Hangzhou, China

Research Site Jinan, China

View Trial Details

Recruiting

Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)

NCT05580601

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Recruiting

Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

NCT07434063

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +4 more
Locations: HebeiMuFH Shijiazhuang, Hebei, China

View Trial Details

Recruiting

CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction

NCT06389305

Conditions: Acute Lymphoblastic Leukemia, in Relapse, B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, +21 more
Locations: Beijing GoBroad Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

NCT07422337

Conditions: B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia, B-Cell Lymphoblastic Leukemia, +26 more
Locations: Arkansas Children's Little Rock, Arkansas, United States

Arkansas Children's Northwest Springdale, Arkansas, United States

View Trial Details

Recruiting

HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib

NCT03850366

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancy, +3 more
Locations: Henry Ford hospital Detroit, Michigan, United States

View Trial Details

Recruiting

Atrial Fibrillation in Beta-Thalassemia

NCT05508932

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations: Matteo Bertini Ferrara, Italy

View Trial Details

Recruiting

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

NCT06773208

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Memorial Sloan Kettering at Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities) Commack, New York, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions